Status: Not yet recruiting
Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With
To find out if the amount of CD8 immune cells at the place where TIL cells are collected is linked to how well a patient responds to treatment.
Participants needed: 6
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Sep 15, 2026Locations: 1
Eligibility criteria
Participants must have histologically confirmed advanced melanoma and have been... [+9]
Participants who are not eligible and consented for standard-of-care Iovance TIL... [+4]